Cargando…

Estimating treatment effects for individual patients based on the results of randomised clinical trials

Objectives To predict treatment effects for individual patients based on data from randomised trials, taking rosuvastatin treatment in the primary prevention of cardiovascular disease as an example, and to evaluate the net benefit of making treatment decisions for individual patients based on a pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorresteijn, Johannes A N, Visseren, Frank L J, Ridker, Paul M, Wassink, Annemarie M J, Paynter, Nina P, Steyerberg, Ewout W, van der Graaf, Yolanda, Cook, Nancy R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184644/ https://www.ncbi.nlm.nih.gov/pubmed/21968126 http://dx.doi.org/10.1136/bmj.d5888

Ejemplares similares

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
por: Verhagen, Sandra N, et al.
Publicado: (2011)

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2020)

The daily 10 kcal expenditure deficit: a before-and-after study on low-cost interventions in the work environment
por: Dorresteijn, Johannes A N, et al.
Publicado: (2013)

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
por: Stam‐Slob, Manon C., et al.
Publicado: (2017)

Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?
por: Berkelmans, Gijs F. N., et al.
Publicado: (2020)

The relationship between walking speed and changes in cardiovascular risk factors during a 12-day walking tour to Santiago de Compostela: a cohort study
por: Bemelmans, Remy H H, et al.
Publicado: (2012)

Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial
por: Jaspers, Nicole E M, et al.
Publicado: (2021)

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
por: van der Leeuw, Joep, et al.
Publicado: (2016)

Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives
por: Jaspers, Nicole E M, et al.
Publicado: (2018)

Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model
por: Kaasenbrood, Lotte, et al.
Publicado: (2018)

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study
por: van’t Klooster, Cilie C, et al.
Publicado: (2019)

The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease
por: Schrover, Ilse M, et al.
Publicado: (2018)

Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches
por: Rekkas, Alexandros, et al.
Publicado: (2023)

Treatment of hypercholesterolaemia in older adults calls for a patient-centred approach
por: Kleipool, Emma EF, et al.
Publicado: (2020)

Methods for individualized assessment of absolute risk in case-control studies should be weighted carefully
por: Haaf, Kevin Ten, et al.
Publicado: (2016)

Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models
por: Austin, Peter C, et al.
Publicado: (2014)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Impact of a Patient’s Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision Making
por: de Vries, Tamar I., et al.
Publicado: (2021)

Reclassification calibration test for censored survival data: performance and comparison to goodness-of-fit criteria
por: Demler, Olga V., et al.
Publicado: (2018)

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients
por: Stam-Slob, Manon C., et al.
Publicado: (2016)

Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study
por: Selvarajah, Sharmini, et al.
Publicado: (2011)

Individualized Risk Prediction for Improved Chronic Wound Management
por: Veličković, Vladica M., et al.
Publicado: (2023)

Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction
por: van Kruijsdijk, Rob C M, et al.
Publicado: (2022)

Fine‐Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1
por: Austin, Peter C., et al.
Publicado: (2021)

Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling
por: Couillard, Simon, et al.
Publicado: (2022)

Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models
por: Austin, Peter C., et al.
Publicado: (2022)

Individual participant data meta-analysis with mixed-effects transformation models
por: Tamási, Bálint, et al.
Publicado: (2021)

Comparison of Cardiovascular Risk Factors for Coronary Heart Disease and Stroke Type in Women
por: Leening, Maarten J. G., et al.
Publicado: (2018)

Feature selection and validated predictive performance in the domain of Legionella pneumophila: a comparative study
por: van der Ploeg, Tjeerd, et al.
Publicado: (2016)

Identifying treatment response to antihypertensives in patients with obesity-related hypertension
por: Schrover, Ilse M., et al.
Publicado: (2017)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2019)

Clinical prediction models: a practical approach to development, validation, and updating
por: Steyerberg, Ewout W
Publicado: (2009)

Clinical prediction models : a practical approach to development, validation, and updating /
por: Steyerberg, Ewout W.
Publicado: (2009)

Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2020)

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2021)

Assessment of heterogeneity in an individual participant data meta‐analysis of prediction models: An overview and illustration
por: Steyerberg, Ewout W., et al.
Publicado: (2019)

Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial
por: Vanni, Kathleen M.M., et al.
Publicado: (2020)

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all‐cause mortality: Findings from the SMART cohort
por: Sharif, Shahnam, et al.
Publicado: (2019)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

The impact of estimated glomerular filtration rate equations on chronic kidney disease staging in pediatric renal or heart transplant recipients
por: Vroling, Aram Ben, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e6u0ej7k18o4tkark1f0q5arbc